The impact of body mass index on overall survival in patients with cancer receiving immunotherapy: a dose-response meta-analysis.
作者信息
Kennedy Oliver John, Neary Marianne Therese
机构信息
The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
出版信息
Cancer Immunol Immunother. 2023 Jan;72(1):275-276. doi: 10.1007/s00262-022-03229-x. Epub 2022 Jun 11.
Abstract
摘要
相似文献
1
The impact of body mass index on overall survival in patients with cancer receiving immunotherapy: a dose-response meta-analysis.体重指数对接受免疫治疗的癌症患者总生存期的影响：一项剂量反应荟萃分析。
Cancer Immunol Immunother. 2023 Jan;72(1):275-276. doi: 10.1007/s00262-022-03229-x. Epub 2022 Jun 11.
2
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.体重指数、肥胖与肿瘤浸润淋巴细胞作为免疫治疗患者的预后生物标志物：多参数分析。
Eur J Cancer. 2021 Mar;145:197-209. doi: 10.1016/j.ejca.2020.12.028. Epub 2021 Jan 22.
3
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.体重指数对免疫治疗癌症患者预后和不良事件的预测价值：系统评价和荟萃分析。
Cancer Immunol Immunother. 2021 Aug;70(8):2323-2335. doi: 10.1007/s00262-021-02858-y. Epub 2021 Jan 29.
4
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.肥胖症可能可以预测在接受免疫疗法治疗的 1 期临床试验中的晚期癌症患者的生存情况。
Cancer. 2020 Feb 1;126(3):575-582. doi: 10.1002/cncr.32576. Epub 2019 Oct 24.
5
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer.基线预后营养指数和治疗前体重指数变化与晚期癌症患者的免疫治疗反应相关。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001674.
6
Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review.BMI 对实体瘤免疫治疗生存结局的影响：系统评价。
Int J Mol Sci. 2021 Mar 5;22(5):2628. doi: 10.3390/ijms22052628.
7
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.根据体质量指数评估化疗剂量对卵巢癌生存的影响。
JAMA Oncol. 2015 Sep;1(6):737-45. doi: 10.1001/jamaoncol.2015.1796.
8
Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data.肥胖对癌症免疫疗法的多方面影响：连接临床前模型和临床数据。
Semin Cancer Biol. 2023 Oct;95:88-102. doi: 10.1016/j.semcancer.2023.07.004. Epub 2023 Jul 26.
9
Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.体重指数与免疫检查点抑制剂治疗癌症患者生存结局的关系：系统评价和荟萃分析。
J Transl Med. 2020 Jun 12;18(1):235. doi: 10.1186/s12967-020-02404-x.
10
Body mass index and risk of gastric cancer: a meta-analysis.体重指数与胃癌风险：一项荟萃分析。
Jpn J Clin Oncol. 2014 Sep;44(9):783-91. doi: 10.1093/jjco/hyu082. Epub 2014 Jun 20.
本文引用的文献
1
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.体重指数对免疫治疗癌症患者预后和不良事件的预测价值：系统评价和荟萃分析。
Cancer Immunol Immunother. 2021 Aug;70(8):2323-2335. doi: 10.1007/s00262-021-02858-y. Epub 2021 Jan 29.
2
Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.BMI 与免疫检查点抑制剂治疗晚期非小细胞肺癌的总生存期的相关性。
JAMA Oncol. 2020 Apr 1;6(4):512-518. doi: 10.1001/jamaoncol.2019.5241.
3
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.BMI、irAE 和基因表达特征与肾细胞癌对免疫检查点抑制剂的耐药性和预后相关。
J Transl Med. 2019 Nov 25;17(1):386. doi: 10.1186/s12967-019-02144-7.
4
Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition.体重指数、性别和血清肌酐之间的复杂相互关系对生存的影响：探讨接受检查点抑制治疗的黑色素瘤患者中的肥胖悖论。
J Immunother Cancer. 2019 Mar 29;7(1):89. doi: 10.1186/s40425-019-0512-5.
5
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.一项针对接受抗 PD-1/PD-L1 免疫检查点抑制剂治疗的癌症患者体重指数的多中心研究：超重变得有利。
J Immunother Cancer. 2019 Feb 27;7(1):57. doi: 10.1186/s40425-019-0527-y.
6
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.靶向治疗、免疫治疗或化疗治疗转移性黑色素瘤患者的体重指数与结局的相关性：一项回顾性、多队列分析。
Lancet Oncol. 2018 Mar;19(3):310-322. doi: 10.1016/S1470-2045(18)30078-0. Epub 2018 Feb 12.
Zotero 插件